NASDAQ$BIOLQ

Biolase Inc · Q2 2021 earnings

Q2 2021 earnings · · Investor relations

Briefing

Reported significantly improved revenue driven by high demand for dental lasers from new customers.

BIOLASE reported a strong second quarter with a 211% increase in net revenue to $9.1 million compared to the same period last year. The company's performance was driven by increased demand for dental lasers, with over 70% of U.S. laser sales coming from new customers. The company also provided revenue guidance for the third quarter of 2021, expecting significant year-over-year improvement.

  • Net revenue grew 211% to $9.1 million.
  • Laser system sales increased 424%.
  • Gross margin was 44%, up 1,200 basis points.
  • Net loss was $702,000 or $0.00 per share.

Headline financials

Total Revenue

$9.13M

Previous: $2.94M+210.9%
EPS (adj)

-$0.12

Previous: -$0.12+0.0%
Capital Expenditures

$303K

Previous: $72K+320.8%
Free Cash Flow

-$3.81M

Previous: -$5.28M+27.8%
Net Income

-$702K

Previous: -$4.7M+85.1%
Operating Income

-$3.3M

Previous: -$3.98M+17.1%
Gross Profit

$4.04M

Previous: $941K+329.4%
Cash & Equivalents

$37.1M

Previous: $5.44M+582.4%
Total Assets

$61.2M

Previous: $27.8M+120.7%
Stock-Based Comp

$369K

Previous: $800K-53.9%

Revenue & EPS history

Biolase · Revenue · Quarterly

$9.13M

Q2 2021+210.9%vs Q2 2020
Beat estimate in 7 of 13 quarters(54%)
ActualEstimate

Revenue by segment

Biolase · $6.7M total across 2 segments · Q3 2023

  • US Laser Revenue
    $3.8M-17.4%
  • International Laser Revenue
    $2.9M

Forward guidance

The Company continues to experience high demand for its dental lasers and is currently forecasting revenue for the third quarter ending September 30, 2021, to be significantly above the year-ago third quarter despite the pent up demand the Company experienced in last year’s Q3 as procedure volume dramatically improved from historically low levels in the 2020 second quarter. Even though the third quarter of the year is seasonally our second weakest revenue quarter, we expect the third quarter of 2021 to approach revenues we achieved in the second quarter of 2021.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2021

Historical avgQ2 2021

-3.0%

Avg return

Earnings day

-6.6%

Avg return

5 days after

-13.5%

Avg return

30 days after

41%

24 / 58 earnings

Positive

+25.4%

Q2 2021

Best reaction

-45.7%

Q1 2020

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q3 2024-18.9%-9.9%+26.1%
Q2 2024+7.8%-10.0%-30.0%
Q1 2024+1.8%-10.8%-21.9%
Q4 2024+20.3%+7.5%-6.8%
Q3 2023-22.0%-17.3%-23.4%
Q2 2023-19.5%-6.2%-50.2%
Q1 2023-6.7%-15.4%-17.4%
Q4 2022-10.8%-24.8%-43.8%
Q3 2022+16.3%+27.7%-49.2%
Q2 2022-1.1%-5.3%-33.6%
Q1 2022+0.0%-2.0%-47.1%
Q4 2021+2.9%+4.1%-9.3%
Q3 2021-8.2%-17.9%-34.5%
Q2 2021+25.4%+5.7%+10.0%
Q1 2021-1.2%-1.5%-10.8%
Q3 2020-3.3%-10.4%-0.8%
Q2 2020-2.4%-4.7%-28.9%
Q1 2020-45.7%-49.0%-6.0%
Q4 2019-22.4%-52.1%-7.3%
Q3 2019-5.8%+6.3%+2.9%
Q2 2019-7.7%-12.3%-36.1%
Q1 2019+2.5%-8.4%-13.9%
Q4 2018-16.5%-18.0%-21.6%
Q3 2018-9.3%-9.3%-27.9%
Q2 2018+9.5%+29.9%+60.6%
Q1 2018-2.4%+1.1%-13.1%
Q4 2017-4.1%-7.8%-36.7%
Q3 2017+0.0%+0.0%-25.0%
Q2 2017-29.8%-32.3%-28.8%
Q1 2017-3.8%-3.0%-3.8%
Q4 2016-2.5%-4.2%+5.8%
Q3 2016+20.8%+20.1%+18.8%
Q2 2016+1.8%+12.4%+56.6%
Q1 2016-12.3%
Q4 2015-0.8%
Q3 2015+8.5%
Q2 2015+6.3%
Q1 2015+1.0%
Q4 2014-2.5%
Q3 2014-3.3%
Q2 2014+1.4%
Q1 2014-0.8%
Q4 2013+0.7%
Q3 2013-11.8%
Q2 2013-22.7%
Q1 2013+3.5%
Q4 2012+1.0%
Q3 2012+10.6%
Q2 2012-1.2%
Q1 2011+0.8%
Q1 2012+1.8%
Q4 2011+0.5%
Q4 2009+0.5%
Q3 2011+4.9%
Q3 2010+4.9%
Q2 2010-10.2%
Q4 2010-10.2%
Q2 2011-10.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro